Prof. Dr. Uluhan Sili

A Case of Vancomycin-Associated Neutropenia

Flora the Journal of Infectious Diseases and Clinical Microbiology, 2026

DOI 10.5578/flora.2026031615 Texte intégral en libre accèsSource : ORCID

Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey

International Journal of STD & AIDS, 2026

DOI 10.1177/09564624251374810 PMID 40891926 Texte intégral en libre accèsSource : ORCID

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study

Open Forum Infectious Diseases, 2026

DOI 10.1093/ofid/ofag133 PMID 41918958 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study

Newcastle University ePrints (Newcastle Univesity), 2026

DOI 10.25405/ncl.34545600 Texte intégral en libre accèsSource : OpenAlex

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry

American Journal of Hematology, 2025

DOI 10.1002/ajh.70166 PMID 41439460 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

MARMARA ÜNİVERSİTESİ PENDİK EĞİTİM VE ARAŞTIRMA HASTANESİ’NDE TAKİP EDİLEN HIV İLE YAŞAYAN BİREYLERİN KEMİK MİNERAL YOĞUNLUKLARININ DEĞERLENDİRİLMESİ

ANKEM Dergisi, 2025

DOI 10.54962/ankemderg.1737161 Texte intégral en libre accèsSource : ORCID

HIV İLE YAŞAYAN BİREYLERDE HLA-B*57:01 POZİTİFLİK DÜZEYİ

Kocatepe Tıp Dergisi, 2025

DOI 10.18229/kocatepetip.1575855 Texte intégral en libre accèsSource : ORCID

Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1

Current HIV Research, 2025

DOI 10.2174/011570162x340918250312040500 PMID 40129156 Source : ORCID

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Infection, 2024

DOI 10.1007/s15010-023-02169-7 PMID 38388854 8 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study

Scientific Reports, 2024

DOI 10.1038/s41598-024-55886-w PMID 38433274 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

eClinicalMedicine, 2024

DOI 10.1016/j.eclinm.2024.102553 PMID 38533127 38 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry

Haematologica, 2024

DOI 10.3324/haematol.2023.284678 PMID 38572549 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry

Hematological Oncology, 2024

DOI 10.1002/hon.3240 PMID 38050405 16 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission

Turkish Journal of Internal Medicine, 2024

DOI 10.46310/tjim.1502238 Texte intégral en libre accèsSource : OpenAlex

Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic

Turkish Journal of Pharmaceutical Sciences, 2024

DOI 10.4274/tjps.galenos.2023.47105 PMID 38742835 Texte intégral en libre accèsSource : ORCID

Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry

International Journal of Infectious Diseases, 2024

DOI 10.1016/j.ijid.2023.12.006 PMID 38128643 12 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

The Journal of Infectious Diseases, 2024

DOI 10.1093/infdis/jiad423 PMID 38349333 13 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Investigation of toxoplasma seropositivity in adult individuals infected with HIV followed at Marmara University Pendik Training and Research Hospital, 2024

Turkish Bulletin of Hygiene and Experimental Biology, 2024

DOI 10.5505/turkhijyen.2024.40501 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Investigation of syphilis seropositivity in adult individuals living with HIV followed at Marmara University Pendik Training and Research Hospital, 2024

Turkish Bulletin of Hygiene and Experimental Biology, 2024

DOI 10.5505/turkhijyen.2024.04207 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

International Journal of Infectious Diseases, 2023

DOI 10.1016/j.ijid.2023.10.013 PMID 37863310 16 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

International Journal of Antimicrobial Agents, 2023

DOI 10.1016/j.ijantimicag.2023.106952 PMID 37582478 12 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

HemaSphere, 2023

DOI 10.1097/01.hs9.0000972964.65137.d1 Texte intégral en libre accèsSource : ORCID

Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.

Infectious diseases & clinical microbiology, 2023

DOI 10.36519/idcm.2023.206 PMID 38633015 Texte intégral en libre accèsSource : ORCID

Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study

Vaccine, 2023

DOI 10.1016/j.vaccine.2023.05.052 PMID 37277251 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Türkiye'de Bir Yenidoğan Yoğun Bakım Ünitesinde Sağlık Hizmetlerine Bağlı Enfeksiyonların Özellikleri

Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 2023

DOI 10.38136/jgon.994734 Texte intégral en libre accèsSource : ORCID

Effect of video camera monitoring feedback on hand hygiene compliance in neonatal intensive care unit, an interventional study

American Journal of Infection Control, 2023

DOI 10.1016/j.ajic.2022.12.011 PMID 36603809 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

The Lancet Infectious Diseases, 2023

DOI 10.1016/s1473-3099(22)00872-6 PMID 37254300 124 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study

AIDS Patient Care and STDs, 2023

DOI 10.1089/apc.2022.0206 PMID 36812461 6 citations (Europe PMC) Source : ORCID

The Incidence and Factors Affecting the 28-day Hospital Admission among Adult Ambulatory COVID-19 Patients

Klimik Dergisi, 2023

DOI 10.36519/kd.2023.4510 Texte intégral en libre accèsSource : ORCID

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

EClinicalMedicine, 2023

DOI 10.1016/j.eclinm.2023.101939 PMID 37041967 36 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Blood, 2022

DOI 10.1182/blood.2022017257 PMID 36126318 75 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

Cancers, 2022

DOI 10.3390/cancers14225530 PMID 36428621 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

HemaSphere, 2022

DOI 10.1097/hs9.0000000000000789 PMID 36310756 29 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

ASSOCIATION OF LATITUDE AND ALTITUDE WITH COVID-19 SYMPTOMS: SCCM DISCOVERY VIRUS REGISTRY ANALYSIS

Critical Care Medicine, 2022

Source : ORCID

Admission Code Status and End-of-life Care for Hospitalized Patients With COVID-19

Journal of Pain and Symptom Management, 2022

DOI 10.1016/j.jpainsymman.2022.06.014 PMID 35764202 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

eLife, 2022

DOI 10.7554/elife.80556 PMID 36197074 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

Frontiers in Oncology, 2022

DOI 10.3389/fonc.2022.992137 PMID 36276116 18 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Blood, 2022

DOI 10.1182/blood.2021014124 PMID 34748627 82 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort

Current HIV Research, 2022

DOI 10.2174/1570162x19666211119111740 PMID 34802406 5 citations (Europe PMC) Source : ORCID

Pharmacokinetic characterization of favipiravir in patients with COVID-19

British Journal of Clinical Pharmacology, 2022

DOI 10.1111/bcp.15227 PMID 35014080 21 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells

Vaccine, 2022

DOI 10.1016/j.vaccine.2022.03.001 PMID 35339303 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

HemaSphere, 2022

DOI 10.1097/01.hs9.0000844012.13018.0a 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The Association of Latitude and Altitude with COVID-19 Symptoms: A VIRUS: COVID-19 Registry Analysis

The Open Respiratory Medicine Journal, 2022

DOI 10.2174/18743064-v16-e2207130 PMID 37273949 Texte intégral en libre accèsSource : OpenAlex

Peripheral innate and adaptive immune cells during COVID ‐19: Functional neutrophils, pro‐inflammatory monocytes, and half‐dead lymphocytes

Cytometry Part B Clinical Cytometry, 2021

DOI 10.1002/cyto.b.22042 PMID 34846101 14 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

The Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19

International Journal of Endocrinology, 2021

DOI 10.1155/2021/2395212 PMID 34422043 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Blood, 2021

DOI 10.1182/blood-2021-147295 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Journal of Hematology & Oncology, 2021

DOI 10.1186/s13045-021-01177-0 PMID 34649563 253 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Development of a pseudovirus-based assay for analysis of neutralizing activity against SARS-CoV-2 in convalescent plasma

European Journal of Immunology, 2021

Source : ORCID

Frequency and associated factors for carbapenem-non-susceptible Bacteroides fragilis group bacteria colonization in hospitalized patients: Case control study in a university hospital in Turkey

Indian Journal of Medical Microbiology, 2021

DOI 10.1016/j.ijmmb.2021.03.018 PMID 33812722 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study

Marmara Medical Journal, 2021

DOI 10.5472/marumj.942700 Texte intégral en libre accèsSource : ORCID